American Journal of Epidemiology Vol. 125, No. 1: 133-139
Copyright © 1987 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
THE EFFECT OF UNDERREPORTING ON THE APPARENT INCIDENCE AND EPIDEMIOLOGY OF ACUTE VHIAL HEPATITIS
1Hepatitis Branch, Division of Viral Diseases, Center for Infectious Diseases, Centers for Disease Control Atlanta, GA 30333
2Tacoroa-Pierce County Health Department Tacoma, WA.
To determine if passively reported cases of acute viral hepatitis are representative of the affected population, an active surveillance system was set up that identified all persons in Pierce County, Washington, who had been diagnosed by a physician as having acute viral hepatitis in the period March 1 through August 31, 1984. In this county, this was part of an ongoing epidemiologic study of viral hepatitis that had previously included some stimulation of reporting. The active surveillance system covered all primary sources of medical care, including all private physicians who were most likely to see persons with hepatitis. Secondary sources, those that did not provide direct medical care but might be aware of new cases, were also surveyed. The results of active surveillance showed that passive reporting was about 65% complete in Pierce County. No change occurred in the number of hepatitis A cases reported, but hepatitis B cases increased by 50%, and non-A, non-B hepatitis cases increased by 138%. Most of the increase was a result of enhanced reporting from private physicians. The two risk groups most affected by underreporting were homosexual men with hepatitis B and blood transfusion recipients with non-A, non-B hepatitis. During active surveillance, the proportion of persons with hepatitis B who reported homosexual activity was 52% compared with 20% from passive surveillance. Transfusion recipients represented 24% of the non-A, non-B hepatitis reported from active surveillance compared with 9% reported from passive surveillance. Although Pierce County may not be representative of all counties in the United States, persons responsible for public hearth prevention programs should recognize that data acquired through passive surveillance may not accurately reflect the magnitude of the risk for specific populations or the amount of disease that can be prevented.
hepatitis A; hepatitis B; hepatitis; viral; non-A; non-B
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. W. Hutton, D. Tan, S. K. So, and M. L. Brandeau Cost-Effectiveness of Screening and Vaccinating Asian and Pacific Islander Adults for Hepatitis B Ann Intern Med, October 2, 2007; 147(7): 460 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wasley, T. Samandari, and B. P. Bell Incidence of Hepatitis A in the United States in the Era of Vaccination JAMA, July 13, 2005; 294(2): 194 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dagan, A. Leventhal, E. Anis, P. Slater, Y. Ashur, and D. Shouval Incidence of Hepatitis A in Israel Following Universal Immunization of Toddlers JAMA, July 13, 2005; 294(2): 202 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Haley and R. P. Fischer The Tattooing Paradox: Are Studies of Acute Hepatitis Adequate to Identify Routes of Transmission of Subclinical Hepatitis C Infection? Arch Intern Med, May 12, 2003; 163(9): 1095 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Doyle, M. K. Glynn, and S. L. Groseclose Completeness of Notifiable Infectious Disease Reporting in the United States: An Analytical Literature Review Am. J. Epidemiol., May 1, 2002; 155(9): 866 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Koo, P. O'Carroll, and M. LaVenture Public Health 101 for Informaticians J. Am. Med. Inform. Assoc., November 1, 2001; 8(6): 585 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Jacobs, H. S. Margolis, and P. J. Coleman The Cost-effectiveness of Adolescent Hepatitis A Vaccination in States With the Highest Disease Rates Arch Pediatr Adolesc Med, August 1, 2000; 154(8): 763 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Fendrick, J. H. Lee, C. LaBarge, and H. A. Glick Clinical and Economic Impact of a Combination Haemophilus influenzae and Hepatitis B Vaccine: Estimating Cost-effectiveness Using Decision Analysis Arch Pediatr Adolesc Med, February 1, 1999; 153(2): 126 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Wetterhall, M. E. Cogswell, and K. V. Kowdley Public Health Surveillance for Hereditary Hemochromatosis Ann Intern Med, December 1, 1998; 129(11_Part_2): 980 - 986. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Rej Liver diseases and the clinical laboratory—the Twentieth Arnold O. Proceedings of the 20th Arnold O. Beckman Conference in Clinical Chemistry Clin. Chem., August 1, 1997; 43(8): 1473 - 1475. [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Noskin Prevention, Diagnosis, and Management of Viral Hepatitis: A Guide for Primary Care Physicians Arch Fam Med, November 1, 1995; 4(11): 923 - 934. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Krahn and A. S. Detsky Should Canada and the United States Universally Vaccinate Infants against Hepatitis B?: A Cost - Effectiveness Analysis Med Decis Making, February 1, 1993; 13(1): 4 - 20. [Abstract] [PDF]
|
|
|
|
|
|
T. M. O'Neill, A. V. Abbott, and S. E. Radecki Risk of Needlesticks and Occupational Exposures Among Residents and Medical Students Arch Intern Med, July 1, 1992; 152(7): 1451 - 1456. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Alter, S. C. Hadler, F. N. Judson, A. Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, L. A. Moyer, H. A. Fields, D. W. Bradley, et al. Risk Factors for Acute Non-A, Non-B Hepatitis in the United States and Association With Hepatitis C Virus Infection JAMA, November 7, 1990; 264(17): 2231 - 2235. [Abstract] [PDF]
|
|
|
|
|
|
J. E. Everhart, A. M. Di Bisceglie, L. M. Murray, H. J. Alter, J. J. Melpolder, G. Kuo, and J. H. Hoofnagle Risk for Non-A, Non-B (Type C) Hepatitis through Sexual or Household Contact with Chronic Carriers Ann Intern Med, April 1, 1990; 112(7): 544 - 545. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Alter, S. C. Hadler, H. S. Margolis, W. J. Alexander, P. Y. Hu, F. N. Judson, A. Mares, J. K. Miller, and L. A. Moyer The Changing Epidemiology of Hepatitis B in the United States: Need for Alternative Vaccination Strategies JAMA, March 2, 1990; 263(9): 1218 - 1222. [Abstract] [PDF]
|
|
|
|
|
|
Racial Differences in Rates of Hepatitis B Virus Infection--United States, 1976-1980 JAMA, January 5, 1990; 263(1): 29 - 30. [PDF]
|
|
|
|
|
|
T. L. Chorba, R. L. Berkelman, S. K. Safford, N. P. Gibbs, and H. F. Hull Mandatory Reporting of Infectious Diseases by Clinicians JAMA, December 1, 1989; 262(21): 3018 - 3026. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Alter, P. J. Coleman, W. J. Alexander, E. Kramer, J. K. Miller, E. Mandel, S. C. Hadler, and H. S. Margolis Importance of Heterosexual Activity in the Transmission of Hepatitis B and Non-A, Non-B Hepatitis JAMA, September 1, 1989; 262(9): 1201 - 1205. [Abstract] [PDF]
|
|
|
|
|
|
W. W. WILLIAMS, M. A. HICKSON, M. A. KANE, A. P. KENDAL, J. S. SPIKA, and A. R. HINMAN Immunization Policies and Vaccine Coverage Among Adults: The Risk for Missed Opportunities Ann Intern Med, April 1, 1988; 108(4): 616 - 625. [Abstract] [PDF]
|
|